Aptus Capital Advisors’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29.8M | Buy |
64,080
+2,959
| +5% | +$1.24M | 0.2% | 94 |
|
|
2026
Q1 | $23.1M | Buy |
61,121
+3,740
| +7% | +$1.6M | 0.18% | 104 |
|
|
2025
Q4 | $24.6M | Buy |
57,381
+757
| +1% | +$330K | 0.18% | 115 |
|
|
2025
Q3 | $25.4M | Buy |
56,624
+6,368
| +13% | +$2.88M | 0.18% | 116 |
|
|
2025
Q2 | $24.5M | Buy |
50,256
+5,210
| +12% | +$2.97M | 0.2% | 104 |
|
|
2025
Q1 | $27.7M | Buy |
45,046
+4,351
| +11% | +$2.47M | 0.29% | 76 |
|
|
2024
Q4 | $21.6M | Buy |
40,695
+7,327
| +22% | +$4.13M | 0.23% | 99 |
|
|
2024
Q3 | $20.1M | Buy |
33,368
+4,291
| +15% | +$2.43M | 0.3% | 81 |
|
|
2024
Q2 | $15.8M | Sell |
29,077
-8,787
| -23% | -$5.03M | 0.28% | 81 |
|
|
2024
Q1 | $24.3M | Buy |
37,864
+3,438
| +10% | +$2.09M | 0.45% | 50 |
|
|
2023
Q4 | $20.1M | Sell |
34,426
-2,752
| -7% | -$1.54M | 0.55% | 40 |
|
|
2023
Q3 | $19.3M | Sell |
37,178
-1,319
| -3% | -$686K | 0.53% | 40 |
|
|
2023
Q2 | $20.9M | Buy |
38,497
+3,699
| +11% | +$2.02M | 0.5% | 45 |
|
|
2023
Q1 | $18.7M | Sell |
34,798
-233
| -0.7% | -$119K | 0.5% | 39 |
|
|
2022
Q4 | $17.9M | Sell |
35,031
-18,803
| -35% | -$9.15M | 0.55% | 36 |
|
|
2022
Q3 | $23.5M | Buy |
53,834
+16,590
| +45% | +$7.98M | 0.57% | 30 |
|
|
2022
Q2 | $17.5M | Buy |
37,244
+11,299
| +44% | +$5.51M | 0.45% | 31 |
|
|
2022
Q1 | $13.1M | Buy |
25,945
+2,683
| +12% | +$1.29M | 0.33% | 38 |
|
|
2021
Q4 | $12.3M | Buy |
23,262
+3,822
| +20% | +$1.84M | 0.37% | 39 |
|
|
2021
Q3 | $9.04M | Buy |
19,440
+2,433
| +14% | +$1.15M | 0.23% | 54 |
|
|
2021
Q2 | $8.07M | Buy |
17,007
+2,130
| +14% | +$1.02M | 0.24% | 54 |
|
|
2021
Q1 | $6.84M | Buy |
14,877
+386
| +3% | +$189K | 0.25% | 57 |
|
|
2020
Q4 | $7.72M | Buy |
14,491
+3,719
| +35% | +$1.83M | 0.35% | 52 |
|
|
2020
Q3 | $5.17M | Buy |
10,772
+1,659
| +18% | +$814K | 0.27% | 63 |
|
|
2020
Q2 | $4.11M | Buy |
9,113
+583
| +7% | +$260K | 0.26% | 63 |
|
|
2020
Q1 | $3.69M | Buy |
8,530
+6,555
| +332% | +$2.93M | 0.32% | 59 |
|
|
2019
Q4 | $868K | Buy |
1,975
+303
| +18% | +$127K | 0.06% | 180 |
|
|
2019
Q3 | $698K | Sell |
1,672
-403
| -19% | -$165K | 0.04% | 205 |
|
|
2019
Q2 | $748K | Buy |
2,075
+325
| +19% | +$109K | 0.11% | 148 |
|
|
2019
Q1 | $560K | Buy |
1,750
+750
| +75% | +$230K | 0.1% | 147 |
|
|
2018
Q4 | $283K | Buy |
+1,000
| New | +$302K | 0.07% | 96 |
|
Other funds holding CHE
EIP
Aptus Capital Advisors's CHE Position: Q2 2026 in Review
Aptus Capital Advisors increased its Chemed (CHE) stake by 4.8% in Q2 2026, buying an estimated $1.24M and bringing the position to 64,080 shares worth $29.8M. The position accounts for 0.2% of the portfolio, ranked #94.
Aptus Capital Advisors first reported a position in CHE in Q4 2018 and has held it in 31 quarters since. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.
- Aptus Capital Advisors held 64,080 shares of Chemed worth $29.8M as of Q2 2026.
- Aptus Capital Advisors bought 2,959 Chemed shares in Q2 2026, an estimated $1.24M.
- Chemed made up 0.2% of Aptus Capital Advisors's portfolio in Q2 2026, its #94 holding.
- Aptus Capital Advisors first reported a position in Chemed in Q4 2018 and has held it in 31 quarters since.
- 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.
Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.